{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:36:42Z","timestamp":1775151402705,"version":"3.50.1"},"reference-count":61,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2007,6,27]],"date-time":"2007-06-27T00:00:00Z","timestamp":1182902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The presence of genetic mutations in HIV\u20101\u2010positive untreated individuals and its contribution to treatment failure, either in an individual or on a population basis, remains an important concern. The goal was to analyze and compare HIV\u20101 reverse transcriptase (RT) and protease (PR) genes of untreated individuals with chronic and recent infections. Fifty\u2010one chronic infected individuals for whom initiation of antiretroviral treatment had been recommended and 20 individuals with recent documented HIV\u20101 seroconversion had their plasma viral RNA extracted and the PR and RT genes sequenced in order to determine subtype, presence of genetic polymorphisms and mutations associated with resistance to antiretroviral drugs. All 20 recent seroconvertors were infected with subtype B viruses. Of the 51 chronically infected patients, 40 (78.4%), 7 (13.7%), and 2 (3.9%) were infected with subtypes B, F, and C, respectively. Two (3.9%) hybrid forms were also observed in two individuals with chronic infection: D\/B and D\/F. Despite seroconversion stage, type and quantity of mutations were similar to both groups (<jats:italic>P<\/jats:italic>\u2009=\u20090.961). This group also presented the only (1.4%) drug\u2010resistance mutation (M184V) among all samples investigated. In summary, the present study shows a high occurrence of equivalent polymorphisms unrelated to drug resistance in samples collected from untreated HIV\u20101\u2010 infected individuals in different seroconversion status, and suggests low primary resistance mutations. Results also indicate that non\u2010B subtypes circulating in Rio de Janeiro have specific Brazilian non\u2010synonymous mutations. J. Med. Virol. 79: 1033\u20131039, 2007. \u00a9 2007 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/jmv.20845","type":"journal-article","created":{"date-parts":[[2007,6,27]],"date-time":"2007-06-27T16:22:31Z","timestamp":1182961351000},"page":"1033-1039","source":"Crossref","is-referenced-by-count":10,"title":["Human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns among treatment\u2010naive patients in different stages of infection in Rio de Janeiro, Brazil"],"prefix":"10.1002","volume":"79","author":[{"given":"Rafael Brand\u00e3o","family":"Varella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selma Ba\u00eda","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcia Braga","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano Gustavo","family":"Zalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa Dias","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,6,27]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199905280-00015"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200103300-00009"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200204010-00015"},{"key":"e_1_2_1_5_1","first-page":"51","article-title":"Prevalence of HIV\u20101 resistant strains in recent seroconverters","volume":"14","author":"Balotta C","year":"2002","journal-title":"J Biol Regul Homeost Agents"},{"key":"e_1_2_1_6_1","unstructured":"BarretoCC NishiyaAS BuschMP SabinoEC.2004.HIV subtype and drug resistance among recent and long\u2010standing infected blood donors from Sao Paulo Brazil. Abstract 842. 11th Conference on Retroviruses and Opportunistic Infections San Francisco CA. USA."},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0901-1016"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.12.1135"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-200002010-00011"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(00)00270-3"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1128\/AAC.43.7.1674","article-title":"Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals","volume":"43","author":"Brindeiro R","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.12.4512-4519.2002"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200305020-00016"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00126334-200102010-00006","article-title":"Primary genotypic and phenotypic HIV\u20101 drug resistance in recent seroconverters in Madrid","volume":"26","author":"Briones C","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200311210-00016"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X1998001000002"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000131394.76221.02"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762005000100014"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1995.11.1143"},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/135965350000500112","article-title":"The relation between baseline HIV drug resistance and response to antiretroviral therapy: Re\u2010analysis of retrospective and prospective studies using a standardized data analysis plan","volume":"5","author":"De Gruttola V","year":"2000","journal-title":"Antivir Ther"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.9.3075-3079.2002"},{"key":"e_1_2_1_22_1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00126334-200103010-00010","article-title":"Frequency of genotypic and phenotypic drug\u2010resistant HIV\u20101 among therapy\u2010naive patients of the German seroconverter study","volume":"26","author":"Duwe S","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2003.00730.x"},{"key":"e_1_2_1_24_1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/135965350300800605","article-title":"Nucleoside and nucleotide analogue reverse transcriptase inhibitors: A clinical review of antiretroviral resistance","volume":"8","author":"Gallant JE","year":"2003","journal-title":"Antivir Ther"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1086\/323601"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199802000-00005"},{"key":"e_1_2_1_27_1","first-page":"215","article-title":"Drug resistance mutations in HIV\u20101","volume":"11","author":"Johnson VA","year":"2003","journal-title":"Top HIV Med"},{"key":"e_1_2_1_28_1","first-page":"125","article-title":"Update of the drug resistance mutations in HIV\u20101: Fall 2006","volume":"14","author":"Johnson VA","year":"2006","journal-title":"IAS"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1086\/382488"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/5.2.150"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2004.04.004"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.12.1142"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013552"},{"key":"e_1_2_1_34_1","unstructured":"LittleSJ KoelschKK IgnacioCC WongJK LieY FrostSDW RichmanDD.2004.Persistence of Transmitted drug\u2010resistant virus among subjects with primary HIV infection deferring antiretroviral therapy. Abstract 36LB. 11th Conference on Retroviruses and Opportunistic Infections San Francisco CA. USA."},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2003.08.001"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200307250-00012"},{"key":"e_1_2_1_37_1","unstructured":"MasquelierB PillayD van der HoekL PrinsM BalestreE NielsenC PedersenC del RomeroJ OrtizM BalottaC RezzaG GiffordR PorterK.and the CASCADE Virology Collaboration.2004.Changes in prevalence and characteristics of transmitted resistance over time among European seroconverter cohorts. Abstract 683. 11th Conference on Retroviruses and Opportunistic Infections San Francisco CA. USA."},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199808150-00011"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-1-200107030-00005"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1086\/382485"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1086\/318538"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1086\/323604"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1086\/314709"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199811010-00017"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.1.426-430.2004"},{"key":"e_1_2_1_47_1","first-page":"134","volume-title":"HIV sequence compendium","author":"Qui\u00f1ones\u2010Mateu ME","year":"2001"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199611000-00018"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200001280-00003"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1089\/08892220050058362"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762003000600021"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200301030-00004"},{"key":"e_1_2_1_53_1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/135965350200600406","article-title":"Antiretroviral treatment failure and HIV\u20101 genotypic resistance in Sao Paulo, Brazil","volume":"6","author":"Sucupira MC","year":"2001","journal-title":"Antivir Ther"},{"key":"e_1_2_1_54_1","unstructured":"SucupiraMCA TescarolloG JaniniM CaseiroMM AlvesK SabinoEC Castelo\u2010FilhoA Page\u2010ShaferK DiazRS.2004.High Levels of Primary Antiretroviral Genotipic Resistance and B\/F Recombinants in Santos SP Brazil. Abstract 676. 11th Conference on Retroviruses and Opportunistic Infections San Francisco CA. USA."},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(200006)61:2<181::AID-JMV2>3.0.CO;2-T"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/43.2.253"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6532(01)00249-9"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7294.1087"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.8.4836-4847.2003"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)12262-6"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200111230-00010"},{"key":"e_1_2_1_62_1","unstructured":"YerlyS G\u00fcnthardH TelentiA SchifferV ChaveJP VernazzaP BattegayM FurrerH BurgisserP ChanzyB HirschelB PerrinL.Swiss HIV Cohort Study.2004.Changes in Transmission of Drug\u2010resistant Variants a Word of Caution. Abstract 680. 11th Conference on Retroviruses and Opportunistic Infections San Francisco CA. USA."}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.20845","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.20845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T19:46:50Z","timestamp":1699991210000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.20845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,27]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1002\/jmv.20845"],"URL":"https:\/\/doi.org\/10.1002\/jmv.20845","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,27]]}}}